A recent preprint study conducted by Bruce Paterson's team at InCellDX, a research company specializing in test and treatment protocols for Long Covid and post-vaccine syndrome, has shed light on how to distinguish between the two conditions. The study suggests that while both long Covid patients (PASC) and post-vaccination individuals experience similar symptoms such as fatigue, neuropathy, brain fog, and headache, there are key differences that can help differentiate between the two.
According to the study, long Covid patients typically suffer from additional symptoms such as shortness of breath and loss of taste/smell. On the other hand, post-vaccination individuals with PASC-like symptoms did not report these specific symptoms. Although the study group consisted of only 50 patients, the findings provide a promising way to identify and differentiate between long Covid and post-vaccine syndrome.
Dr. Paterson's treatment protocol involves the use of Maraviroc, an HIV drug, and atorvastatin to target vasculature inflammation. However, it is worth noting that other doctors have found success with a different treatment protocol using ivermectin, N-acetylcysteine (NAC), and nattokinase. The varying treatment approaches highlight the need for further research to determine the most effective strategies for managing these conditions.
While the study provides valuable insights into distinguishing between PASC and post-vaccine syndrome, it is important to acknowledge its limitations. The small sample size and the need for further research may impact the generalizability of the findings. However, this preliminary study serves as a stepping stone in understanding and addressing the unique challenges posed by these conditions.
In conclusion, the recent preprint study by Bruce Paterson's team at InCellDX offers a potential way to differentiate between long Covid and post-vaccine syndrome. By analyzing the presence or absence of specific symptoms such as shortness of breath and loss of taste/smell, medical professionals can better diagnose and treat individuals experiencing post-vaccination symptoms. However, further research is needed to validate these findings and establish standardized treatment protocols.
